Renal Cancer

A Phase 1/2 Study Evaluating the Efficacy and Safety of the Oral CXCR4 Inhibitor X4P-001 in Combination with Axitinib in Patients with Advanced Renal Cell Carcinoma. April 24, 2019

Assessment of concomitant non-oncologic medication in patients with surgically treated renal cell carcinoma: impact on prognosis, cell-cycle progression and proliferation. April 24, 2019

Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy. April 24, 2019

The potential role of miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell carcinoma. April 24, 2019

SGK2 promotes renal cancer progression via enhancing ERK 1/2 and AKT phosphorylation. April 23, 2019

Identification of key genes involved in the metastasis of clear cell renal cell carcinoma. April 23, 2019

The tumor microenvironment in renal cell cancer. April 23, 2019

FDA Approves Merck’s Keytruda® (pembrolizumab) in Combination with Inlyta® (axitinib) as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma (RCC) April 22, 2019

DNA methylation of metallothionein genes is associated with the clinical features of renal cell carcinoma. April 22, 2019

Real-world Experience of Cabozantinib as Second- or Subsequent Line Treatment in Patients With Metastatic Renal Cell Carcinoma: Data From the Polish Managed Access Program. April 22, 2019

Prediction of ISUP grading of clear cell renal cell carcinoma using support vector machine model based on CT images. April 22, 2019

C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas. April 19, 2019

Metformin Induces Different Responses in Clear Cell Renal Cell Carcinoma Caki Cell Lines. April 19, 2019

Rising Serum Uric Acid Level Is Negatively Associated with Survival in Renal Cell Carcinoma. April 19, 2019

Impact of tumor size on cancer specific mortality after local tumor ablation in T1a renal cell carcinoma. April 18, 2019

The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma. April 18, 2019

Association of Systemic Inflammation Index and Body Mass Index With Survival in Patients With Renal Cell Cancer Treated With Nivolumab. April 18, 2019

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma. April 17, 2019

Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma. April 17, 2019

The Association of Androgen Receptor Expression with Renal Cell Carcinoma Risk: a Systematic Review and Meta-Analysis. April 17, 2019

Page 1 of 273

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.